A 26-year-old man, the third participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical … Full Article http://j.gs/5sTq
Click here to read full articleA 26-year-old man, the third participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical … Full Article http://j.gs/5sTq
Click here to read full article
No comments:
Post a Comment